Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Durvalumab, Bevacizumab, Placebo, Clinical endpoint, and Gerontology.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association
In‐hospital opioid consumption, but not pain intensity scores, predicts 6‐month levels of pain catastrophizing following hepatic resection: A trajectory analysis
Defining Surgical Quality in Gastric Cancer: A RAND/UCLA Appropriateness Study
Processes of Care in the Multidisciplinary Treatment of Gastric Cancer